Kumar Neil (CIK 1742485) reported 165 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-08). Recent activity: Sell BBIO (2,200 shares), Sell BBIO (4,415 shares), Sell BBIO (15,921 shares), Sell BBIO (450 shares), Sell BBIO (2,200 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-08 | BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer | Sell | 2,200 | $144,584 |
| 2026-06-08 | BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer | Sell | 4,415 | $304,455 |
| 2026-06-08 | BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer | Sell | 15,921 | $1.1M |
| 2026-06-08 | BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer | Sell | 450 | $30,721 |
| 2026-06-08 | BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer | Sell | 2,200 | $144,584 |
| 2026-06-08 | BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer | Sell | 1,429 | $95,347 |
| 2026-06-08 | BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer | Sell | 15,921 | $1.1M |
| 2026-06-08 | BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer | Sell | 1,429 | $95,347 |
| 2026-06-08 | BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer | Sell | 7,147 | $480,271 |
| 2026-06-08 | BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer | Sell | 8,437 | $572,744 |
| 2026-06-08 | BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer | Sell | 4,416 | $304,524 |
| 2026-06-08 | BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer | Sell | 7,148 | $480,338 |
| 2026-06-08 | BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer | Sell | 8,437 | $572,744 |
| 2026-06-08 | BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer | Sell | 450 | $30,721 |
| 2026-05-19 | BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer | Buy | 33,544 | $0 |
| 2026-05-19 | BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer | Buy | 19,599 | $0 |
| 2026-05-19 | BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer | Buy | 11,553 | $0 |
| 2026-05-19 | BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer | Buy | 6,519 | $0 |
| 2026-05-19 | BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer | Sell | 36,236 | $2.4M |
| 2026-05-11 | BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer | Sell | 449 | $31,022 |
| 2026-05-11 | BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer | Sell | 8,333 | $569,790 |
| 2026-05-11 | BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer | Sell | 450 | $31,091 |
| 2026-05-11 | BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer | Sell | 11,217 | $757,090 |
| 2026-05-11 | BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer | Sell | 8,334 | $569,858 |
| 2026-05-11 | BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer | Sell | 11,217 | $757,091 |
Source: SEC Form 4 filings · as of 2026-06-08